Leap Therapeutics (LPTX) Net earnings per share growth forecast for next year

Symbol and logo of brand Leap Therapeutics, Inc. (LPTX)

The stability of Leap Therapeutics, Inc. (LPTX) is based on support from pharma giants and the outcomes of antibody tests. Patents and strict FDA oversight ensure a high barrier to entry. The company's ecosystem relies on targeted therapy for gastrointestinal cancers using DKN-01. The 12-month forward EPS projection vector in the GURU.Markets system contains data where the indicator remains around 0.00.

LPTX - Leap Tx Earnings growth forecast for next year over the range 07/04/2022 - 11/13/2025

Metric breakdowns and analytics for Leap Therapeutics, Inc. (LPTX)

- price and consensus price forecast:
Analysis of all company metrics:Leap Therapeutics, Inc.
Core merchandise of Leap Tx

Amid market volatility, capital preservation requires an analysis of future returns. The development of targeted schemes using the DKN-01 antibody for gastrointestinal cancer therapy by Leap Therapeutics, Inc. (LPTX) creates a foundation for business scaling. The current EPS growth forecast for the next period on GURU.Markets reflects analyst consensus expectations for net income dynamics, allowing investors to assess the potential for share price appreciation through future financial results.

Direct competitors

Net earnings per share growth forecast for next year immunitybio.com|Expected earnings per share growth for next year immunocore.com (IMCR)|Net earnings per share growth forecast for next year Janux Therapeutics Inc (JANX)|Expected earnings per share growth for next year Arcus Bio RCUS|Zymeworks Inc - Expected earnings per share growth for next year|Earnings growth forecast for next year Tango Therapeutics Corp TNGX|IOVA - Net earnings per share growth forecast for next year|IMTX (immatics.com) - Projected earnings per share growth rate for next year|Xencor Inc. (XNCR) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Compass Bio (CMPX)|Expected earnings per share growth for next year REPL|LYEL - Net earnings per one share growth forecast for next year|Expected earnings per share growth for next year IPHA (Innate Pharma, S.A.)|Projected earnings per share increase next year PYXS|Earnings growth forecast for next year CGEN (Compugen Ltd.)|Expected earnings per share trend next year IOBT|sutrobio.com - Earnings growth forecast for next year|Expected net earnings per share growth next year MiNK Therapeutics, Inc|Werewolf (HOWL) - Net earnings per share growth forecast for next year|Immix Biopharma Inc. - Expected earnings per share trend next year|ALXO (alxoncology.com) - Earnings growth forecast for next year|Cue Biopharma, Inc. - Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year pdsbiotech.com (PDSB)|SONN: Net earnings per share change forecast for next year|MAIA Biotech - Expected earnings per share growth for next year|liminatuspharma.com (LIMN) - Expected net earnings per share growth next year|LVTX - Net earnings per share growth forecast for next year|NXTC (NextCure) - Projected earnings per share growth rate for next year|Intensity Therapeutics (INTS) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Sensei Bio (SNSE)|TOVX (Theriva Biologics Inc) - Earnings growth forecast for next year|Gritstone bio (GRTS) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year KA|Consensus forecast of earnings per share growth for next year NexImmune Inc|Net earnings per share growth forecast for next year turnstonebio.com TSBX|Consensus forecast of earnings per share growth for next year Vaccinex Inc (VCNX)|HARP - Net earnings per share growth forecast for next year